Documente Academic
Documente Profesional
Documente Cultură
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
EXERCISE 1
TERMS TO DEFINE
PHARMACY
DRUGS POISON
CODE
BIOLOGIC PRODUCTS WHOLESALER DEVICE CIPHER
SECRET KEYS
PHARMACEUTICAL MEDICINES
BIO-REF
Single proprietorship cert. of business name registration (BDT of DTI) Partnerships, corporations cert. of registration (SEC) and articles of Incorporation or partnership
Notarized petition/Joint affidavit Tentative list of products Floor area (nlt 15 sq.m) Generic white and red labels Rubber stamp of outlets Pharmacist
Registration cert. PRC-ID valid PTR ID picture cert. of attendance to BFAD seminar
Single proprietorship
Corporation
Contract of lease Picture of drugstore with signboard
Requirement
Petition Form
Requirement
Joint Affidavit of
Undertaking
License To Operate
Pharmacist
Registration of
certificate
Pharmacist
Business Registration
Pharmacist
PRC ID
Pharmacist
Certificate of attendance
REFERENCE BOOKS
PNDF RA 3720 RA 6675 RA 5921 RA 8203 USP/NF RPS Goodman and Gilman Pharmacological Basis of Therapeutics
Reference Book
Philippine National Drug
Formulary
Reference Book
Remington
Pharmaceutical Sciences
Reference Book
UNITED STATE
PHARMACOPEIA
RECORD BOOKS
Prescription Book
Dangerous Drug Book Poison Book
Prescription Book
Prescription Book
POISON/CHEMICAL BOOK
OPIUM BOOK
PRESCRIPTION BOOK
INTERNSHIP 1
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
EXERCISE NO. 2
Terms To Define
STATUTORY LAW
COMMON LAW ETHICS
REGULATORY LAW
JURISPRUDENCE
is an act regulating the practice of pharmacy and setting standards of pharmaceutical education in the Philippines and other purposes
this is an act to ensure the safety and purity of foods and cosmetics, and the purity, safety, efficacy, and quality of drugs and devices being made available to the public vesting the BFAD with authority to administer and enforce the laws pertaining thereto
SPECIAL LAW ON COUNTERFEIT DRUGS R.A. 8203 It is an act prohibiting counterfeit drugs, providing penalties for violations and appropriating funds. The BFAD of the Department of Health is authorized to administer and supervise the implementation of this Act which was approved on September 4, 1996.
It is act to promote, require, and ensure the production of an adequate supply, distribution, use and acceptance of drugs and medicines identified by their generic names.
It is an act instituting the Comprehensive Dangerous Drugs Act of 2002, repealing Republic Act No. 6425, otherwise known as the Dangerous Drugs Act of 1972
EXPANDED SENIOR CITIZEN ACT R.A. 9257 An act granting additional benefits and privileges to senior citizens amending for the purpose RA No. 7432, otherwise known as An act to maximize the contribution of senior citizens to nation building, grant benefits and special privileges and for other purposes
It is an act to protect the interest of the consumer, promote his general welfare and to establish standards of conduct for business and industry.
.
CODE OF ETHICS
IMPORTANCE
States publicly the principles that form the fundamental basis of pharmacists roles and responsibilities Guides them in their relationship with patients, health professionals and society
INTERNSHIP 1
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
EXERCISE 3
TRADITIONAL MARKET
DRUGSTORE
PERSONNEL
STORE HOURS NON-TRADITIONAL MARKET
Customer services
Equipment /facilities
Staffing pattern
Pharmacist
Communication
Store facilities
Capitalization Transportation
INTERNSHIP 1
By: Nelson T. Tubon, B.S. Pharm.; B.S. S. Ed.; R.Ph.; M.S. Pharm.; Ph.D. B.M.
Exercise 4
PNDF
DANGEROUS DRUGS BFAD
THERAPEUTIC COMMITTEES
CORE/ MAIN LIST COMPLEMENTARY LIST
therapeutically equivalent drugs Drugs formulated as single compounds Period review of drug list
conditions not already covered in existing list Drug is more effective / less toxic than the drug listed for same medication Drug is at least as effective and safe and of lower cost than the drug listed for same indication Drug is essential for specific DOH health project
toxic drug becomes available The therapeutic efficacy of drug is found to be unsatisfactory or questionable Toxicity/suspected toxicity or potential for abuse or dangerous interactions outweigh its therapeutic value Disuse of drug and no longer available
to other therapies The drug is a fixed dose combination which does not satisfy the requirements of AO 96 s. 1990
Core List
Acetylcysteine Azathioprine Clofazimine Cobra antivenin Dantrolene Diazepam Diethylcarbamazepine Diphtheria-tetanus toxoids Dimercaprol endrophonium Ergocalciferol Fluorecein Folic acid Hydrochlorthiazide Hydrocortisone Hydroxycobalamine Indomethacin inj Iodine INH + ethambutol INH + rifampicin
INH+ Rifampicin+ PZA Levodopa + Thiacetazone Lorazepam Methylene blue N-acetyl penicillamine Neostigmine Nicotinamide ORS 75 replacement Potassium Pot. phosphate
Praziquantrel Retinol Na Ca edetate NaI 131I Na nitrite Na nitroprusside Na thiosulfate Succimer Thiamine Tuberculin purified protein derivative
Complementary List
Aciclovir eye ointment Alpha-tocopherol Al acetate Cromolyn Buserelin Busulfan Chloral hydrate Chlormethine
Dithranol
estramustine
Hydroxycobalamin Indomethacin Iodamide Iron dextran Povidone iodide Pralidoxime Cl Pyrimethamine Recombinant tissue plasminogen activator Rifabutin Rose bengal
Silver nitrate
Spectinomycin Terizodone Tetracosactide Thiacetazone
Varicella zoster Ig
Vasopressin Yerba buena Zinc
Alprazolam Bromazepam
Morphine Nalbuphine
chemicals (A2)
Tsaang gubat
Yerba buena